| Literature DB >> 15158551 |
Jean Carruthers1, Alastair Carruthers.
Abstract
First used and approved over a decade ago for the treatment of strabismus (or misaligned eyes), botulinum toxin (BTX) has demonstrated efficacy in blepharospasm, hemifacial spasm, spastic lower eyelid entropion, and a number of other disorders seen in the traditional medical environment that are characterized by abnormal muscle contraction. Moreover, other conditions-notably some pain and gastrointestinal disorders-have responded to BTX injections.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15158551 DOI: 10.1016/j.clindermatol.2003.11.013
Source DB: PubMed Journal: Clin Dermatol ISSN: 0738-081X Impact factor: 3.541